Mouwasat Medical Services Co. reported a 27% year-on-year profit increase in 2025, with net profits reaching SAR 822 million compared to SAR 645.8 million in 2024. The company attributed this growth to lower financing costs, reduced provisions for receivables impairments, and improved collections. Khalid Alsaleem, the Managing Director, highlighted strong inpatient occupancy growth driven by expanded subspecialties and medical expertise across its hospitals. The company is advancing multiple expansion projects, including the opening of Yanbu Hospital in February 2026 and Jeddah Hospital later this year. These developments position Mouwasat to capitalize on rising healthcare demand in Saudi Arabia. For investors, Mouwasat's consistent profit growth and strategic expansion align with Saudi Arabia's Vision 2030 healthcare sector goals. The company's focus on horizontal and vertical growth through new facilities and specialized services could enhance its market share in the competitive healthcare industry. Traders may monitor the company's stock performance ahead of the Jeddah Hospital opening, which could drive revenue growth and investor confidence. Looking ahead, the successful execution of expansion projects and the timing of hospital openings will be critical for sustaining revenue momentum. MENA investors should watch for updates on construction progress and how the company manages operational costs during expansion. The healthcare sector's resilience amid economic fluctuations also makes Mouwasat an attractive long-term investment option.
مباشر